Trial intelligence / Profile preview

Comparative study of efficacy and safety of GO-ON and Hyalgan in patients with symptomatic osteoarthritis of the knee

2008-003875-35Phase 4Completed

Sponsor
Rottapharm Biotech
Start
Nov 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of sodium hyaluronate in knee osteoarthritis (OA) (2 arms), sponsored by Rottapharm Biotech. Started Nov 2008; status: completed.

02

Drugs

sodium hyaluronate
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on 2008-003875-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-003875-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call